Marshall Wace

Marshall Wace LLP is an employee-owned hedge fund manager established in 1997 and headquartered in London, United Kingdom, with additional offices in New York and Hong Kong. The firm specializes in global long/short equity investment strategies, managing hedge funds and equity mutual funds for its clients. Marshall Wace employs both quantitative and fundamental analysis to identify investment opportunities across public equity markets and alternative investments worldwide. It offers a diverse range of products, allowing investors to choose funds that combine different sources of alpha and beta. The firm is recognized for its strong performance, having been awarded Management Firm of the Year by the EuroHedge Awards in 2011. Marshall Wace's investment approach integrates traditional stock-specific research with its proprietary systematic alpha capture strategy, known as MW TOPS, to deliver persistent, risk-adjusted returns.

Marber, Anthony Patrick Henry

Head of Investor Relations

33 past transactions

InspireMD

Post in 2023
InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD’s mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis. InspireMD intends to pursue applications of its innovative technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.

ACELYRIN

Series C in 2022
ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.

Amun

Venture Round in 2022
Amun is a technology company that creates financial on-ramps to acquire, trade, and secure crypto assets. Individual customers and institutions can use our products to get crypto exposure in a safe, regulated, and easy manner.

Turtlemint

Series E in 2022
Turtlemint is an online insurance platform that identifies and purchases appropriate insurance policies for consumers. It aims to “demystify” insurance by explaining the jargon in a simple way and providing smart tools to help a user make the right choice. From search to purchase, the entire process can be completed online in just a few clicks. The company offers car insurance, bike insurance, health insurance, and term life insurance. It was founded in 2015 and is based in Mumbai, Maharashtra, India.

Circle

Private Equity Round in 2022
Circle is a financial technology company that leverages blockchain technology to facilitate the sending, receiving, and investing of cryptocurrency assets globally. Founded in 2013 by Jeremy Allaire and Sean Neville, Circle offers a user-friendly online platform that simplifies money transfers and includes services such as Circle Pay for peer-to-peer payments. In addition, the company provides Circle Invest, allowing users to buy and sell cryptocurrencies, and Circle Trade, which operates a trading desk with a substantial liquidity pool for digital assets, averaging $2 billion in monthly trading volume. With significant backing from investors, including notable firms such as Goldman Sachs and Accel Partners, Circle has established a presence in major cities, including Boston, New York, San Francisco, Dublin, London, and Hong Kong. The company is dedicated to accelerating global crypto innovation and adoption through its various financial services.

Parse Biosciences

Series B in 2022
Parse Biosciences, based in Seattle, Washington, focuses on single-cell analysis and was incorporated in 2018. The company is dedicated to developing innovative technologies that enhance the understanding of cellular diversity and function at the single-cell level. By leveraging advanced methodologies, Parse Biosciences aims to provide researchers with powerful tools for exploring complex biological systems, ultimately advancing the fields of genomics and biomedical research.

Consensys

Series D in 2022
ConsenSys is a leading blockchain technology company focused on developing the next generation of the internet, referred to as Web 3.0. This new framework aims to create more open, efficient, and accessible economic systems. ConsenSys builds platforms, applications, and tools tailored for Web 3.0, while also providing services to ensure their offerings meet customer needs. As a blockchain venture production studio, it creates consumer-centric products and enterprise solutions, primarily utilizing Ethereum technology. The company serves as a hub for identifying development opportunities, facilitating the sharing of software components across ventures, and fostering innovation through collaboration among some of the industry's top blockchain experts.

Metagenomi

Series B in 2022
Metagenomi, Inc. is a genetic medicines company based in Emeryville, California, focused on developing innovative gene editing systems for the treatment of genetic diseases. Since its incorporation in 2016, the company has utilized a proprietary metagenomics-derived genome editing toolbox that enables the creation of curative therapeutics. This toolbox encompasses a range of advanced technologies, including programmable nucleases, base editors, and various RNA and DNA-mediated integration systems, such as prime editing systems and CRISPR-associated transposases (CASTs). Metagenomi aims to address the challenges posed by diverse mutations that have traditionally been difficult to target with existing genome engineering approaches.

Libra

Series E in 2022
Lukka is a leading technology and data services provider for middle and back-office crypto asset processing. Its crypto-native products connect, standardize, reconcile, process, and report audit-ready information within a highly secure SOC 1 Type 2 enterprise-grade infrastructure. Lukka was founded in 2014 and headquartered in New York, United States.

Accelerant

Private Equity Round in 2022
Accelerant Holdings Ltd. is a wholesale insurance managing general agent (MGA) that primarily serves the small and medium-sized enterprise (SME) market. Founded in 2018 and headquartered in London, United Kingdom, the company operates as an underwriting group, focusing on a carefully selected and managed network of members. By providing tailored insurance solutions, Accelerant aims to address the unique needs of SMEs, fostering a strong support system within this sector.

Tipalti

Series F in 2021
Tipalti is a cloud-based platform that automates and streamlines the payment process for companies, enabling them to efficiently manage payments to suppliers, partners, and publishers. Founded in 2010 and headquartered in San Mateo, California, with an additional office in Kibbutz Glil-Yam, Israel, Tipalti offers a comprehensive solution that encompasses supplier onboarding, tax compliance, invoice processing, and global funds disbursement. The platform simplifies accounts payable tasks, including payment reconciliation and multi-entity payables, while ensuring adherence to IRS tax and VAT regulations. By using Tipalti, organizations can significantly reduce their supplier payment workload, facilitating scalable growth and enhancing financial controls, thus improving the overall payment experience for partners and suppliers. The company primarily serves industries such as ad networks, affiliate networks, eCommerce, and online marketplaces.

TRM Labs

Series B in 2021
TRM Labs is a regulatory technology startup that aims to streamline compliance in the crypto industry.They believe that blockchain can enable a world where value flows freely by democratizing the creation of property rights, reducing transaction, bargaining, and coordination costs, and enabling new ways to organize human behavior.

Consensys

Series C in 2021
ConsenSys is a leading blockchain technology company focused on developing the next generation of the internet, referred to as Web 3.0. This new framework aims to create more open, efficient, and accessible economic systems. ConsenSys builds platforms, applications, and tools tailored for Web 3.0, while also providing services to ensure their offerings meet customer needs. As a blockchain venture production studio, it creates consumer-centric products and enterprise solutions, primarily utilizing Ethereum technology. The company serves as a hub for identifying development opportunities, facilitating the sharing of software components across ventures, and fostering innovation through collaboration among some of the industry's top blockchain experts.

ACELYRIN

Series B in 2021
ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.

Acrivon Therapeutics

Series B in 2021
Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success.

Vayana Network

Venture Round in 2021
Vayana Network is a financing network that enables Businesses and their Trade Partners to capture their entire receivable and payable trades electronically and finance through Banks and Financial Institutions. Businesses can finance their payables, or factor their receivables or make financing available to their counterparties. Vayana Network, in partnership with MasterCard and Banks, also offers its award winning Commercial Card solution for Payable financing.

Cred

Series E in 2021
CRED is a members-only app that rewards the user with exclusive rewards for paying credit card bills. The company is committed to protecting the data and information of its members. CRED works on the guiding principle of opt-In consent and full transparency. The company's security processes and technology implementations combined with regulatory compliance is how it access, store, and use member data.

Varo

Series E in 2021
Varo Money, Inc. is a digital bank based in San Francisco, California, that offers a range of online banking products and services, including bank and savings accounts, checking accounts, and overdraft protection. Established in 2015 and known for being the only U.S. consumer fintech with a national bank charter, Varo aims to serve as a comprehensive banking partner for millions of Americans, especially those seeking better financial solutions. The company combines fintech innovation with the security of a chartered bank, providing tools and insights to enhance financial resilience for its customers. Varo's platform also includes features such as spending analysis, real-time budgeting, cash flow forecasts, direct deposits, and online bill payments, all designed to empower users to make informed financial decisions and improve their overall financial well-being.

Varo

Series E in 2021
Varo Money, Inc. is a digital bank based in San Francisco, California, that offers a range of online banking products and services, including bank and savings accounts, checking accounts, and overdraft protection. Established in 2015 and known for being the only U.S. consumer fintech with a national bank charter, Varo aims to serve as a comprehensive banking partner for millions of Americans, especially those seeking better financial solutions. The company combines fintech innovation with the security of a chartered bank, providing tools and insights to enhance financial resilience for its customers. Varo's platform also includes features such as spending analysis, real-time budgeting, cash flow forecasts, direct deposits, and online bill payments, all designed to empower users to make informed financial decisions and improve their overall financial well-being.

INBRACE

Series D in 2021
Swift Health Systems Inc., a medical device company, develops invisible orthodontic solutions. The company develops InBrace, an orthodontic system that is hidden behind the teeth to correct malocclusion (crooked teeth). Swift Health Systems Inc. was incorporated in 2014 and is based in Irvine, California.

Asher Bio

Series B in 2021
Asher Biotherapeutics, Inc. is a biotechnology company focused on developing immunotherapy drugs for cancer treatment. Founded in 2019 and headquartered in South San Francisco, California, the company aims to create innovative therapeutic solutions to improve patient outcomes in oncology. Asher Bio leverages advanced technologies and research to enhance the effectiveness of immune-based therapies, positioning itself as a key player in the evolving field of cancer treatment.

Neurogastrx

Series B in 2021
Neurogastrx, Inc. is a venture-stage biopharmaceutical company focused on developing products for gastrointestinal disorders. Established in 2017 and headquartered in Campbell, California, the company is known for its innovative product NG101, which aims to enhance gastric motility and possesses antiemetic properties.

Amylyx Pharmaceuticals

Series C in 2021
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

Circle

Private Equity Round in 2021
Circle is a financial technology company that leverages blockchain technology to facilitate the sending, receiving, and investing of cryptocurrency assets globally. Founded in 2013 by Jeremy Allaire and Sean Neville, Circle offers a user-friendly online platform that simplifies money transfers and includes services such as Circle Pay for peer-to-peer payments. In addition, the company provides Circle Invest, allowing users to buy and sell cryptocurrencies, and Circle Trade, which operates a trading desk with a substantial liquidity pool for digital assets, averaging $2 billion in monthly trading volume. With significant backing from investors, including notable firms such as Goldman Sachs and Accel Partners, Circle has established a presence in major cities, including Boston, New York, San Francisco, Dublin, London, and Hong Kong. The company is dedicated to accelerating global crypto innovation and adoption through its various financial services.

Pine Labs

Venture Round in 2021
Pine Labs Private Limited operates a cloud-based unified point-of-sale (POS) platform, primarily serving merchants in India, Southeast Asia, and the Middle East. Founded in 1998 and headquartered in Noida, India, the company provides a range of digital payment acceptance and merchant commerce solutions, including Android-based smart POS devices. Pine Labs offers several features to enhance the merchant experience, such as instant equated monthly installment payment options, loyalty programs, gift cards, and customer analytics. Its myPlutus app provides real-time transaction data, while Promozone facilitates targeted promotional campaigns. The platform supports over 350,000 POS terminals across 3,700 locations, serving more than 100,000 merchants in various sectors, including electronics, food and beverage, and fashion. Additionally, Pine Labs collaborates with financial institutions and brands to create value for retail customers, thereby simplifying payment acceptance and enhancing the overall transaction experience.

Forge Biologics

Series B in 2021
Forge Biologics is a gene therapy development engine founded in 2020 and headquartered in Grove City, Ohio. The company specializes in the development and manufacturing of gene therapies, focusing on transforming innovative concepts into accessible treatments for rare genetic diseases. With end-to-end capabilities, Forge Biologics helps accelerate gene therapy programs from preclinical stages through to clinical and commercial-scale production. The company collaborates with various stakeholders in the gene therapy community, including scientists, healthcare professionals, biotech and pharmaceutical companies, and patient advocacy groups. Among its notable initiatives is a unique approach combining adeno-associated virus (AAV) vectors and umbilical cord transplants to treat infantile Krabbe disease, a severe neurodegenerative disorder. Through its comprehensive services, Forge Biologics aims to provide transformative medicines that improve patient outcomes.

Exscientia

Series D in 2021
Exscientia is applying AI and big data processing to accelerate drug discovery and development. At the forefront of small molecule drug discovery. They are the first company to automate drug design, surpassing conventional human endeavor. Their AI-driven systems actively learn best practice from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters. With better information to hand than any researcher could acquire individually, their knowledge-driven systems design millions of novel, project-specific compounds and pre-assess each for predicted potency, selectivity, ADME and other key criteria. From this, a selection of the best, information-rich compounds are selected for synthesis and assay. With new experimental data generated, the results are integrated and the next design cycle initiated. Rapid design-make-test cycles ensure unparalleled progress towards desired project goals. Exscientia has already delivered exceptional productivity, generating candidates in roughly one-quarter of the time of traditional approaches.

Flywire

Series F in 2021
Flywire operates an online payment platform that facilitates both domestic and international transactions, catering primarily to the education and healthcare sectors. The platform enables users, including international students and patients seeking medical care abroad, to make payments in various currencies through familiar online and offline options. By leveraging vertical-specific insights and technology, Flywire streamlines the payment process and enhances operational efficiency while minimizing risks associated with invoicing and payment reconciliation. The company, which was founded in 2009 and is headquartered in Boston, Massachusetts, has established partnerships with TRUE North and Adyen to bolster its offerings. With a significant portion of its revenue generated from the Americas, Flywire continues to expand its services to meet the needs of its diverse clientele.

Century Therapeutics

Series C in 2021
Century Therapeutics, Inc. is a biotechnology company focused on developing induced pluripotent stem cell (iPSC)-based therapies for cancer treatment. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company aims to create allogeneic living drugs that specifically target both hematologic and solid tumors. By utilizing iPSCs, Century Therapeutics can engineer immune effector cells through multiple rounds of cellular modification, producing master cell banks that can be expanded and differentiated for therapeutic use. Their innovative approach incorporates advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, along with Allo-Evasion technology, which helps prevent rejection by the host immune system. These advancements position Century Therapeutics to enhance the effectiveness and accessibility of cancer treatments.
International Airlines Group is one of the world's largest airline groups. Transporting passengers and cargo generates revenue. It has multiple subsidiaries and attempts to combine leading airlines in Ireland, the United Kingdom, and Spain. It allows airlines to expand global presence and keep individual brands. Staff reports operating segments in a manner consistent with resource-allocation decisions, and are listed as four subsidiaries: British Airways, Iberia, Vueling, and Aer Lingus. Each segment is managed as individual operating companies. Revenue is split between the United Kingdom (roughly one third), Spain, the United States, and the rest of the world.

LGI Homes

Post in 2020
LGI Homes, Inc. designs, constructs, and sells homes in the United States. It offers entry-level homes, such as detached and attached homes, and move-up homes under the LGI Homes brand name; and luxury series homes under the Terrata Homes brand name. As of March 31, 2020, it owned 113 communities. The company serves in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, South Carolina, Washington, Tennessee, Minnesota, Oklahoma, Alabama, California, Oregon, Nevada, and West Virginia. LGI Homes, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.